緩和的な一次全身抗癌療法を受ける転移性大腸癌患者における循環腫瘍DNAと対応する腫瘍組織DNAの縦断的比較解析

Leeら（Mon,）がこの問題を研究した。

www.synapsesocial.com/papers/68e6d064b6db64358764e7c0 — DOI: https://doi.org/10.4143/crt.2024.016

Also consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1. Cancer Statistics in Korea: Incidence, Mortality, Survival, and Prevalence in 2020· 2023 · 225 citations
2. Driver Mutation Variant Allele Frequency in Circulating Tumor DNA and Association with Clinical Outcome in Patients with Non–Small Cell Lung Cancer and EGFR- and KRAS-Mutated Tumors· 2022 · 10 citations
3. The Genome Analysis Toolkit: A MapReduce framework for analyzing next-generation DNA sequencing data· 2010 · 29,782 citations
4. Effects of KRAS, BRAF, NRAS, and PIK3CA mutations on the efficacy of cetuximab plus chemotherapy in chemotherapy-refractory metastatic colorectal cancer: a retrospective consortium analysis· 2010 · 2,134 citations
5. The mutational constraint spectrum quantified from variation in 141,456 humans· 2020 · 278 citations